Legend Biotech - American Depositary Shares (LEGN) closed at $19.27 on October 23, 2026, up 2.0% from the previous close, on volume of 895,476 shares (30-day average 2,216,103).
Data as of October 23, 2026.
23-Oct-2026
Globe Newswire (Thu, 15-Oct 8:00 AM ET)
Globe Newswire (Thu, 1-Oct 9:00 AM ET)
Globe Newswire (Fri, 25-Sep 7:00 AM ET)
Legend Biotech Appoints Ingrid Zhang as Chief Executive Officer
Globe Newswire (Tue, 15-Sep 8:00 AM ET)
Globe Newswire (Thu, 10-Sep 8:00 AM ET)
Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference
Globe Newswire (Tue, 1-Sep 8:00 AM ET)
Legend Biotech Achieves Profitability and Breakthroughs in Cell Therapy with Q2 2026 Results
Market Chameleon (Tue, 11-Aug 3:35 AM ET)
Legend Biotech Reports Second Quarter 2026 Results and Recent Highlights
Globe Newswire (Tue, 11-Aug 7:00 AM ET)
Legend Biotech to Host Investor Conference Call on Second Quarter 2026 Results
Globe Newswire (Tue, 28-Jul 8:00 AM ET)
Legend Biotech Navigates CEO Transition with Emphasis on Continuity and Growth Momentum
Market Chameleon (Mon, 27-Jul 3:29 AM ET)
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
Legend Biotech - American Depositary Shares trades on the NASDAQ stock market under the symbol LEGN.
As of October 23, 2026, LEGN stock price climbed to $19.27 with 895,476 million shares trading.
LEGN has a beta of 1.37, meaning it tends to be more sensitive to market movements. LEGN has a correlation of 0.06 to the broad based SPY ETF.
LEGN has a market cap of $3.75 billion. This is considered a Mid Cap stock.
Last quarter Legend Biotech - American Depositary Shares reported $388 million in Revenue and $.16 earnings per share. This beat revenue expectation by $34 million and missed earnings estimates by -$.09.
In the last 3 years, LEGN traded as high as $70.13 and as low as $16.24.
The top ETF exchange traded funds that LEGN belongs to (by Net Assets): IBB, IEMG, PBE, CANC, EEM.
LEGN has underperformed the market in the last year with a return of -39.2%, while the SPY ETF gained +14.3%. In the last 3 month period, LEGN fell short of the market, returning -18.1%, while SPY returned +3.2%. However, in the most recent 2 weeks LEGN has outperformed the stock market by returning +3.5%, while SPY returned -2.4%.
LEGN support price is $18.26 and resistance is $19.54 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LEGN shares will trade within this expected range on the day.
